Solid knowledge in preclinical development
Patrick has acquired a strong knowledge in preclinical development (from early stages up to marketing and life cycle management) through exposure to various domains including:
- New chemical entities (in various therapeutic areas),
- Biological products (such as monoclonal antibodies, bi- or tri-specifics, antibody drug conjugates or peptides),
- Chemical products,
- Food supplements,
- Herbal medicinal products,
- Medical device,
- Vaccines (including mRNA-LNP vaccines) and adjuvants.
Detailed Nonclinical Development Plans
Patrick prepares comprehensive nonclinical development plans tailored to project goals client needs, product specifics, indication and targeted countries in line with the most up-to-date regulatory guidelines.
